On Tuesday, August 11, 2026, a range of Indian stocks are generating significant buzz among investors due to recent corporate developments, financial results, and strategic announcements. While benchmark indices ended marginally higher on Monday, ongoing geopolitical uncertainties, specifically regarding the Strait of Hormuz, continue to influence market sentiment despite strong corporate earnings from various sectors.
The BSE Sensex saw a modest gain of 43.27 points (0.06%) to close at 78,542.44, and the NSE Nifty50 rose 13.15 points (0.05%) to finish at 24,583.80. Several companies are also trading ex-dividend today, including Gland Pharma, Castrol India, Chambal Fertilisers, and Godfrey Phillips.
Key Stocks in Focus
Mahindra and Mahindra (M&M)
The prominent Indian automaker reported robust growth in June 2026. Production volumes increased by 20.4% year-over-year to 101,954 units, while sales volumes climbed 24.8% to 102,710 units. Exports also saw a significant jump of 47.4% year-over-year, reaching 4,159 units.
Bharat Electronics (BEL)
The state-owned defense electronics company has secured additional orders totaling Rs 541 crore since July 31. These significant orders encompass communication equipment, electro-optics, ammunition fuzes, Chemical, Biological, Radiological, and Nuclear (CBRN) systems, along with associated spares and services.
Vodafone Idea
The telecom operator showed signs of financial improvement in the June 2026 quarter. Its net loss narrowed considerably to Rs 3,754 crore, down from Rs 6,608 crore in the corresponding period last year. Revenue increased by 6% year-over-year to Rs 11,689 crore, while EBITDA surged 9.2% year-over-year to Rs 5,034 crore, with margins expanding to 43.1%.
BSE and Wipro
The National Stock Exchange of India (NSE) announced a significant change to its benchmark Nifty 50 index. Effective September 30, 2026, BSE will be included in the Nifty 50, replacing IT major Wipro.
IRB Infrastructure Developers
The road and toll management firm experienced a strong performance in July 2026, with its toll revenue rising 26% year-over-year to Rs 797.7 crore.
Lupin
Pharmaceutical company Lupin received approval from the US Food and Drug Administration (US FDA) for its Sodium Zirconium Cyclosilicate for oral suspension (5g/packet and 10g/packet). This drug is bioequivalent to AstraZeneca's Lokelma and is indicated for treating hyperkalemia in adults.
Gland Pharma
Gland Pharma reported a substantial 47.1% year-over-year increase in net profit to Rs 317 crore for the June 2026 quarter. Revenue grew 19.6% to Rs 1,800.3 crore, and EBITDA rose 33.1% to Rs 489.2 crore, with an improved EBITDA margin of 27.2%.
KEC International
The infrastructure EPC player saw a 41.7% year-over-year decline in net profit to Rs 72.6 crore for the June 2026 quarter. Revenue remained largely flat at Rs 5,023.5 crore, while EBITDA fell 16.9% to Rs 290.8 crore, resulting in a margin contraction to 6%.
Other Notable Movements
- JSW Energy: Added 1,166 MW of renewable capacity since April 2026, surpassing 94% of its FY26 organic capacity addition.
- Zen Technologies: Secured a Rs 295 crore order from the Ministry of Defence for simulators.
- Lloyds Metals & Energy: Reported a 165% YoY surge in net profit to Rs 1,726.6 crore in Q1 FY27.
- Apar Industries: Opened its Qualified Institutional Placement (QIP) on August 11 with a floor price of Rs 14,801.25 per share.
- Kolte-Patil Developers: Swung to a net profit of Rs 146.3 crore in Q1 FY27, compared to a loss in the prior year.
- Texmaco Rail & Engineering: Signed an MoU with The Signalling Company NV, Belgium, for an ETCS solution for the Indian market.
- Lumax Auto Technologies: Net profit more than doubled to Rs 86.6 crore in Q1 FY27, with plans for a new manufacturing facility.
Investors will be closely monitoring these companies as the market reacts to their latest performance figures and strategic announcements.